Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
Hill

S. 5797 was introduced in the Senate and referred to the Finance Committee, directing HHS to create a Medicare demonstration project to expand access to biosimilar biologics.

Why it’s here: A federal bill creating a Medicare demonstration project for biosimilar access falls under biotechnology federal policy (drug pricing and access affecting biotech innovation), though it is a routine referral action with thin substance.

Trace across the board

Item

Connected

3 links

About

  • Medicare
  • Senate Finance Committee Democrats
  • Department of Health and Human Services

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

S. 5797 was introduced in the Senate and referred to the Finance Committee, directing HHS to create a Medicare demonstration project to expand access to biosimilar biologics. — The Wave